Skip to main content
Vcanbio Cell & Gene Engineering Corp., Ltd logo

Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings

Ticker · 600645 ISIN · CNE000000545 LEI · 300300FLWFDJPQYVAZ24 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,580 across all filing types
Latest filing 2008-10-14 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 600645

About Vcanbio Cell & Gene Engineering Corp., Ltd

https://www.vcanbio.com/

Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.

Recent filings

Filing Released Lang Actions
六届三次董事会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at a board meeting of Shanghai Wangchunhua (Group) Co., Ltd., including approval of related party transactions, changes in company name and registration, capital increases, and appointment changes. It also includes an independent directors' opinion on related party transactions and a detailed rectification report responding to regulatory requirements from the Shanghai Securities Regulatory Bureau. The content focuses on board decisions, governance issues, compliance with regulatory directives, and management actions rather than financial results or earnings. There is no indication that this is an annual report, audit report, earnings release, or investor presentation. The document is not a simple announcement of a report publication but a substantive disclosure of board resolutions and governance matters. Therefore, the most appropriate classification is Board/Management Information (MANG), as it primarily concerns board meeting resolutions and management changes.
2008-10-14 Chinese
控股子公司对外投资公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Shanghai Wangchunhua (Group) Co., Ltd. regarding an external investment by its controlling subsidiary. It details the subsidiary's plan to spin off a monoclonal antibody diagnostic reagent business and establish a wholly-owned subsidiary. The document includes information about the investment overview, approval procedures, investment subject, investment target, contract content, impact on the listed company, and risk analysis. There are no financial statements or detailed financial performance data presented. The document is a formal announcement of a corporate investment decision rather than a financial report or regulatory filing. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is not a report publication announcement since it contains substantive information about the investment. The best fitting category is Regulatory Filings (RNS) as it is a general regulatory announcement about a corporate investment by a subsidiary that does not fit other specific categories.
2008-10-14 Chinese
重大诉讼事项公告
Legal Proceedings Report Classification · 100% confidence The document is a public announcement from a company regarding a significant legal proceeding involving a lawsuit filed by a major shareholder against the company. It details the nature of the lawsuit, the amounts involved, and the potential impact on the company's profits. There are no financial statements or detailed financial data presented, nor is this a report or presentation. The content fits the description of a Legal Proceedings Report, which provides updates on significant lawsuits or regulatory actions involving the company.
2008-09-26 Chinese
关于规范部分法人股不合格证券账户的通知
Regulatory Filings Classification · 95% confidence The document is a notification from Shanghai Wangchunhua (Group) Co., Ltd. regarding the regulation of certain non-compliant corporate securities accounts. It references a notice from the China Securities Depository and Clearing Corporation Shanghai Branch about standardizing non-designated trading non-compliant Shanghai A-share securities accounts. The document includes a detailed list of non-compliant accounts and instructions for rectification. There are no financial statements, earnings data, or management discussion. The document is a regulatory announcement about account compliance and does not fit into financial reports or management reports. It is not a report publication announcement since it contains substantive content and details. Therefore, it best fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2008-09-25 Chinese
2008年第三季度业绩预增公告
Earnings Release Classification · 95% confidence The document is a performance forecast announcement for the third quarter of 2008, providing estimated net profit and reasons for growth. It explicitly states that the forecast is preliminary and unaudited, and that actual data will be disclosed in the official third quarter report. The document length is short (634 characters), and it does not contain actual financial statements or detailed financial analysis. It is a forward-looking earnings preview rather than a full earnings release or interim report. Therefore, it fits best as an Earnings Release (ER) type, which covers initial announcements of quarterly financial results or key highlights. 9M 2008
2008-09-19 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding abnormal stock price fluctuations for the company Shanghai Wangchunhua (Group) Co., Ltd. It discusses stock price limits being hit over consecutive trading days, inquiries made to controlling shareholders and management, and confirms no undisclosed material information exists. There is no financial data, no report attached or referenced as being published, and no mention of a meeting or voting results. The document is a regulatory announcement about stock trading behavior and company disclosures, fitting the category of a general regulatory announcement rather than a financial report or other specific filing type.
2008-09-16 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.